Is Corcept Therapeutics Inc halal to invest in?

As of July 2026, Corcept Therapeutics Inc CORT is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Corcept Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Corcept Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Corcept Therapeutics Inc?

Muslim investors may consider investing in Corcept Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Corcept Therapeutics Inc classified as HALAL?

Musaffa determines the Shariah status of Corcept Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Corcept Therapeutics Inc updated?

The Shariah compliance status of Corcept Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Corcept Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Corcept Therapeutics Inc?

You can check the latest Shariah compliance status of Corcept Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CORT Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Corcept Therapeutics Inc is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

Corcept Therapeutics Inc. Stock Analysis CORT

United States Health Care Mid Cap Report: Q1, 2026

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company is headquartered in Redwood City, California and currently employs 730 full-time employees. The company went IPO on 2004-04-15. The firm is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. The firm operates through the discovery, development and commercialization of the pharmaceutical products segment. The firm has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.

Key Statistics of Corcept Therapeutics Inc (CORT)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$92.74$95.65

Today's Open

$95.18

Volume

1.61M

P/E Ratio (TTM)

101.91

52 Week Range

$28.66$95.11

Market Cap

9.98B

Avg. Volume

1.10M

Dividend Yield

Financial Metrics & Statements of Corcept Therapeutics Inc (CORT)

Super Investors Invested in Corcept Therapeutics Inc (CORT)

FAQ's for Corcept Therapeutics Inc (CORT)

As of July 2026, Corcept Therapeutics Inc CORT is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Corcept Therapeutics Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Corcept Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Corcept Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Corcept Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Corcept Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.